Background Several molecular analyses have been investigated for risk stratification of
thyroid nodules, with a particular focus on the V600E mutation of the BRAF gene [BRAF …

Thyroid cancer (TC) represents less than 1% of all newly diagnosed malignancies. In some
selected cases, with a high clinical suspicion for disease but negative I-131 scan, positron …

BRAF (V600E) is the most frequent genetic mutation in papillary thyroid cancer (PTC) and
has been reported as an independent predictor of poor prognosis of these patients. Current …

Purpose The incidence of thyroid cancer (TC) is increasing. Cytology by itself cannot
distinguish TC from some benign nodules especially in certain subtypes of TC. Our …

Abstract Background/Objectives Experimental and clinical studies have shown that vitamins
A and E can inhibit cancer formation and progression. The unfavourable status of these …

It is now known that “gain of function” mutations of RET (REarranged during Transfection)
kinase are specific and key oncogenic events in the onset of thyroid gland cancers such as …

Thyroid cancer has the fastest rising incidence rates and is the fifth most common cancer in
women. There are four main types of which the papillary and follicular types together …

Objective Transcription factor zinc finger E-box-binding homeobox 1 (ZEB1), as one of the
key inducers of epithelial-mesenchymal transition, has been reported to be regulated by …

Background: Differentiated thyroid carcinomas originating from thyroid follicular cells are
frequent tumors of the thyroid with relatively good prognosis due to improved surgical …

Objective To explore the clinicopathological features and relative prognostic risks of the
three major variants of papillary thyroid carcinoma (PTC). Methods We retrospectively …